A. Laplanche

发表

EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype

Xavier Paoletti, François Radvanyi, Fabien Reyal, 2014, Science Translational Medicine.

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

Y Wang, Mike Clarke, Donald A. Berry, 2005, The Lancet.

A direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomas

D. Planchard, F. André, J. Soria, 2011, British Journal of Cancer.

An Analysis of Postoperative Epidural Analgesia Failure by Computed Tomography Epidurography

C. Motamed, A. Laplanche, J. Stéphanazzi, 2006, Anesthesia and analgesia.

Polyadenylic–Polyuridylic Acid Plus Locoregional Radiotherapy Versus Chemotherapy with CMF in Operable Breast Cancer: a 14 Year Follow-up Analysis of a Randomized Trial of the Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCC)

T. Delozier, A. Laplanche, P. Fargeot, 2000, Breast Cancer Research and Treatment.

Prophylactic cranial irradiation in small cell lung cancer.

R. Arriagada, J. Pignon, T. le Chevalier, 2004, Hematology/oncology clinics of North America.

Outcome According to Elective Pelvic Radiation Therapy in Patients With High-Risk Localized Prostate Cancer: A Secondary Analysis of the GETUG 12 Phase 3 Randomized Trial.

S. Culine, N. Salem, M. Baciuchka, 2016, International journal of radiation oncology, biology, physics.

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

Ivanov, Harris, R. Collins, 2005, The Lancet.

Prevention of second primary tumours with a second generation retinoid in squamous cell carcinoma of oral cavity and oropharynx: long term follow-up.

M. Bolla, A. Laplanche, Christian Domenge, 1995, European journal of cancer.

Cisplatin alone or combined with gemcitabine in carcinomas of unknown primary: results of the randomised GEFCAPI 02 trial.

S. Culine, E. Blot, A. Laplanche, 2012, European journal of cancer.

Image-guided Radiation Therapy (IGRT) in Prostate Cancer: Preliminary Results in Prostate Registration and Acute Toxicity of a Randomized Study

R. Crevoisier, J. Bachaud, A. Laplanche, 2009 .

DNA adducts in normal bladder tissue and bladder cancer risk.

A. Laplanche, S. Benhamou, F. Desgrandchamps, 2003, Mutagenesis.

Results of a randomized clinical trial comparing two radiation schedules in the palliative treatment of brain metastases.

C. Haie-meder, R. Arriagada, A. Laplanche, 1993, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

MR imaging of hepatic metastases caused by neuroendocrine tumors: comparing four techniques.

T. de Baère, M. Ducreux, E. Baudin, 2003, AJR. American journal of roentgenology.

Detection of liver metastases from endocrine tumors: a prospective comparison of somatostatin receptor scintigraphy, computed tomography, and magnetic resonance imaging.

T. de Baère, M. Ducreux, E. Baudin, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Benefit of surgery after chemoradiotherapy in stage IIIB (T4 and/or N3) non-small cell lung cancer.

R. Arriagada, F. André, T. le Chevalier, 2001, The Journal of thoracic and cardiovascular surgery.

Impact of monitoring plasma 1,1‐dichlorodiphenildichloroethane (o,p′DDD) levels on the treatment of patients with adrenocortical carcinoma

E. Baudin, G. Vassal, M. Schlumberger, 2001, Cancer.

Bilateral germ-cell tumours: 22-year experience at the Institut Gustave Roussy

C. Théodore, A. Laplanche, K. Fizazi, 2004, British Journal of Cancer.

Limb salvage with isolated perfusion for soft tissue sarcoma: could less TNF-α be better?

J. Blay, P. Terrier, S. Bonvalot, 2005 .

A. Khabir, J. Daoud, M. Frikha, 2003, Cancer detection and prevention.

What We Know About Carcinomas of Unknown Primary Site (CUP) Almost for Sure: Incidence, Survival, and Necropsy Data

A. Laplanche, 2006 .

Not All Patients with a Pancreatic Neuroendocrine Tumour Will Benefit from All Approved or Recommended Therapeutic Options: A Real-Life Retrospective Study

T. de Baère, M. Ducreux, E. Baudin, 2016, Neuroendocrinology.

Radiosensitivity of human normal and tumoral thyroid cells using fluorescence in situ hybridization and clonogenic survival assay.

B. Caillou, A. Laplanche, C. Parmentier, 1999, International journal of radiation oncology, biology, physics.

Ex vivo expanded mobilized peripheral blood CD34+ cells accelerate haematological recovery in a baboon model of autologous transplantation

W. Vainchenker, N. Debili, A. Laplanche, 2000, British journal of haematology.

A phase III trial of personalized chemotherapy based on serum tumor marker decline in poor-prognosis germ-cell tumors: Results of GETUG 13.

S. Culine, C. Logothetis, G. Gravis, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Granulocyte C olony-Stimulati ng F actor i n I nduction Treatment o f C hildren W ith N on-Hodgkin's L ymphoma: A R andomized S tudy o f t he F rench S ociety o f Pediatric O ncology

A. Baruchel, D. Frappaz, C. Patte, 2002 .

Patterns of relapse in poor-prognosis germ-cell tumours in the GETUG 13 trial: Implications for assessment of brain metastases.

S. Culine, C. Logothetis, G. Le Teuff, 2017, European journal of cancer.

Combining gemcitabine, cisplatin, and ifosfamide (GIP) is active in patients with relapsed metastatic germ-cell tumors (GCT): a prospective multicenter GETUG phase II trial.

S. Culine, G. Gravis, N. Houédé, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Limb salvage with isolated perfusion for soft tissue sarcoma: could less TNF-alpha be better?

J. Blay, P. Terrier, S. Bonvalot, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

Prognostic value of urinary N-telopeptide (uNTx) in patients (pts) with castration-resistant prostate cancer (CRPC) and bone metastases

A. Laplanche, K. Fizazi, C. Massard, 2008 .

Intrathecal + PCA morphine improves analgesia during the first 24 hr after major abdominal surgery compared to PCA alone

B. Plaud, B. Debaene, P. Lasser, 2003, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

Prognostic factors for chemoembolization in liver metastasis from endocrine tumors.

T. de Baère, M. Ducreux, E. Baudin, 2004, Hepato-gastroenterology.

Development and validation of a prognostic model to predict the length of survival in patients with carcinomas of an unknown primary site.

S. Culine, A. Laplanche, A. Kramar, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Impact of the extent and duration of cytoreductive surgery on postoperative hematological toxicity after intraperitoneal chemohyperthermia for peritoneal carcinomatosis

M. Pocard, D. Elias, V. Boige, 2005, Journal of surgical oncology.

Earlier Positivity of Central-Venous- versus Peripheral-Blood Cultures Is Highly Predictive of Catheter-Related Sepsis

A. Laplanche, A. Andremont, C. Tancrède, 1998, Journal of Clinical Microbiology.

Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control.

J. Blay, S. Bonvalot, A. Le Cesne, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Flexible fiberoptic bronchoscopy and remifentanil target-controlled infusion in ICU: a preliminary study

A. Laplanche, A. Stoclin, F. Blot, 2012, Intensive Care Medicine.

Long‐term results and prognostic factors in patients with differentiated thyroid carcinoma

B. Caillou, M. Schlumberger, M. Tubiana, 1985, Cancer.

Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial.

P. Rougier, A. Laplanche, M. Huguier, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prevention of oral mucositis in patients treated with high-dose chemotherapy and bone marrow transplantation: a randomised controlled trial comparing two protocols of dental care.

A. Laplanche, E. Benhamou, J. Pico, 1994, European journal of cancer. Part B, Oral oncology.

Prevention of second primary tumours with etretinate in squamous cell carcinoma of the oral cavity and oropharynx. Results of a multicentric double-blind randomised study.

M. Bolla, A. Laplanche, Christian Domenge, 1994, European journal of cancer.

p53 status correlates with histopathological response in patients with soft tissue sarcomas treated using isolated limb perfusion with TNF-alpha and melphalan.

P. Terrier, S. Bonvalot, C. Richon, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC

Olivier Lantz, Laurence Zitvogel, Clotilde Théry, 2015, Oncoimmunology.

Cisplatin in combination with either gemcitabine or irinotecan in carcinomas of unknown primary site: results of a randomized phase II study--trial for the French Study Group on Carcinomas of Unknown Primary (GEFCAPI 01).

P. Petrow, S. Culine, X. Pivot, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Novel Epigenetic Phenotype Associated With the Most Aggressive Pathway of Bladder Tumor Progression

François Radvanyi, Jessica Zucman-Rossi, Jennifer Southgate, 2010, Journal of the National Cancer Institute.

Carcinoma of an unknown primary: are EGF receptor, Her-2/neu, and c-Kit tyrosine kinases potential targets for therapy?

S. Culine, X. Pivot, J. Douillard, 2007, British Journal of Cancer.

Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase III trial (PCI99-01, EORTC 22003-08004, RTOG 0212 and IFCT 99-01).

R. Arriagada, C. Faivre-Finn, S. Senan, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

Patterns of failure after prophylactic cranial irradiation in small-cell lung cancer: analysis of 505 randomized patients.

J. A. Santos-Miranda, R. Arriagada, T. le Chevalier, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

Standard-dose versus higher-dose prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy (PCI 99-01, EORTC 22003-08004, RTOG 0212, and IFCT 99-01): a randomised clinical trial.

R. Arriagada, C. Faivre-Finn, S. Senan, 2009, The Lancet. Oncology.

Controlled clinical trial of prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission.

J. A. Santos-Miranda, R. Arriagada, A. Laplanche, 1998, Lung cancer.

Androgen deprivation therapy plus docetaxel and estramustine versus androgen deprivation therapy alone for high-risk localised prostate cancer (GETUG 12): a phase 3 randomised controlled trial.

A. Ravaud, S. Culine, G. Deplanque, 2015, The Lancet. Oncology.

Should adjuvant radiotherapy be administered in addition to front-line aggressive surgery (FAS) in patients with primary retroperitoneal sarcoma?

P. Terrier, S. Bonvalot, A. Le Cesne, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Diagnosis of catheter-related bacteraemia: a prospective comparison of the time to positivity of hub-blood versus peripheral-blood cultures

C. Brun-Buisson, A. Laplanche, C. Tancrède, 1999, The Lancet.

A risk-adapted study of cisplatin and etoposide, with or without ifosfamide, in patients with metastatic seminoma: results of the GETUG S99 multicenter prospective study.

S. Culine, A. Laplanche, P. Kerbrat, 2014, European urology.

Medullary thyroid carcinoma: prognostic factors and treatment.

B. Caillou, M. Schlumberger, P. Rougier, 1983, International journal of radiation oncology, biology, physics.

Toxicity of fluorouracil in patients with advanced colorectal cancer: effect of administration schedule and prognostic factors.

M. Buyse, J. Pignon, P. Rougier, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The values of calcitonin and carcinoembryonic antigen in the treatment and management of nonfamilial medullary thyroid carcinoma

M. Tubiana, A. Laplanche, G. Milhaud, 1983, Cancer.

An essential role for decorin in bladder cancer invasiveness

Y. Allory, F. Radvanyi, I. Bernard-Pierrot, 2013, EMBO molecular medicine.

PCA analgesia for children with chemotherapy-related mucositis: a double-blind randomized comparison of morphine and pethidine.

D. Orbach, C. Oudot, A. Laplanche, 2011, Bulletin du cancer.

Significant effect of adjuvant chemotherapy on survival in locally advanced non-small-cell lung carcinoma.

R. Arriagada, J. Douillard, T. le Chevalier, 1992, Journal of the National Cancer Institute.

Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients.

R. Arriagada, J. Douillard, T. Chevalier, 1991, Journal of the National Cancer Institute.

High-dose thiotepa-related neurotoxicity and the role of tramadol in children

C. Maritaz, A. Laplanche, A. Laplanche, 2018, BMC Cancer.

CDKN2A homozygous deletion is associated with muscle invasion in FGFR3‐mutated urothelial bladder carcinoma

E. Letouzé, Y. Allory, F. Radvanyi, 2012, The Journal of pathology.

Genetic polymorphisms in 85 DNA repair genes and bladder cancer risk.

Philippe Dessen, Stefan Michiels, Agnès Laplanche, 2009, Carcinogenesis.

Classical external indwelling central venous catheter versus totally implanted venous access systems for chemotherapy administration: a randomized trial in 100 patients with solid tumors.

A. Laplanche, P. Carde, M. Cosset-Delaigue, 1989, European journal of cancer & clinical oncology.

Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer.

M. Buyse, J. Pignon, P. Rougier, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Tandem high-dose chemotherapy with stem cell rescue followed by risk-adapted radiation in children with high-risk cerebral primitive neuroectodermal tumor: Results of the prospective SFCE-trial PNET HR+5.

N. André, D. Frappaz, C. Berger, 2014 .

Medullary thyroid carcinoma as part of a multiple endocrine neoplasia type 2B syndrome

E. Baudin, J. Bidart, B. Caillou, 2002, Cancer.

Hyperthermic Pelvic Perfusion With Tumor Necrosis Factor-&agr; for Locally Advanced Cancers: Encouraging Results of a Phase II Study

S. Bonvalot, A. Eggermont, A. Paci, 2012, Annals of surgery.

Polyadenylic-polyuridylic acid as an adjuvant in resectable colorectal carcinoma: a 6 1/2 year follow-up analysis of a multicentric double blind randomized trial.

P. Lasser, A. Laplanche, D. Gallot, 1992, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Astro plenary: Effect of chemotherapy on locally advanced non-small cell lung carcinoma: A randomized study of 353 patients

R. Arriagada, J. Pignon, J. Douillard, 1991 .

Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: a trial of the gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer.

Agnès Laplanche, Michel Ducreux, M. Ychou, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Granulocyte colony-stimulating factor in induction treatment of children with non-Hodgkin's lymphoma: a randomized study of the French Society of Pediatric Oncology.

A. Baruchel, D. Frappaz, C. Patte, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cost-minimization analysis of prophylactic granulocyte colony-stimulating factor after induction chemotherapy in children with non-Hodgkin's lymphoma.

C. Patte, A. Laplanche, C. Rubino, 1998, Journal of the National Cancer Institute.

Early tracheotomy versus prolonged endotracheal intubation in unselected severely ill ICU patients

T. Similowski, I. Durand-zaleski, P. Chardon, 2008, Intensive Care Medicine.

Radiotherapy alone versus combined chemotherapy and radiotherapy in unresectable non-small cell lung carcinoma.

R. Arriagada, J. Douillard, T. le Chevalier, 1994, Lung cancer.

High subcutaneous adipose tissue predicts the prognosis in metastatic castration-resistant prostate cancer patients in post chemotherapy setting.

B. Escudier, Y. Loriot, A. Laplanche, 2015, European journal of cancer.

CT and MR imaging of squamous cell carcinoma of the tongue and floor of the mouth.

D. Vanel, J. Bosq, F. Eschwège, 1996, Radiographics : a review publication of the Radiological Society of North America, Inc.

Differential time to positivity of central and peripheral blood cultures is inaccurate for the diagnosis of Staphylococcus aureus long-term catheter-related sepsis.

A. Laplanche, E. Chachaty, A. Emirian, 2018, The Journal of hospital infection.

Polyadenylic-polyuridylic acid plus locoregional and pelvic radiotherapy versus chemotherapy with CMF as adjuvants in operable breast cancer. A 6 1/2 year follow-up analysis of a randomized trial of the French Federation of Cancer Centers (F.F.C.C.).

T. Delozier, J. Petit, M. Namer, 1991, Breast cancer research and treatment.

Urinary N-telopeptide (uNTx) is an independent prognostic factor for overall survival in patients with bone metastases from castration-resistant prostate cancer.

B. Escudier, Y. Loriot, A. Laplanche, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase II trial of consolidation docetaxel and samarium-153 in patients with bone metastases from castration-resistant prostate cancer.

V. Haddad, B. Escudier, J. Lumbroso, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Daily Versus Weekly Prostate Cancer Image Guided Radiation Therapy: Phase 3 Multicenter Randomized Trial.

J. Bachaud, R. de Crevoisier, M. Bayar, 2018, International journal of radiation oncology, biology, physics.

83 Prophylactic cranial irradiation (PCI) for patients (PTS) with small cell lung cancer (SCLC) in complete remission (CR)

J. A. Santos-Miranda, R. Arriagada, A. Laplanche, 1995 .

Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial.

S. Culine, C. Logothetis, G. Gravis, 2014, The Lancet. Oncology.

A phase II monocentric study of oxaliplatin in combination with gemcitabine (GEMOX) in patients with advanced/metastatic transitional cell carcinoma (TCC) of the urothelial tract.

R. Crevoisier, F. Bidault, C. Théodore, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

O-64 Long term results in terms of neurotoxicity among patients with limited small cell lung cancer included in a trial evaluating prophylactic cranial irradiation

R. Arriagada, T. Chevalier, A. Laplanche, 2003 .

Chromogranin a Measurement in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Carcinoma: Screening for False Positives and a Prospective Follow-Up Study

M. Ducreux, E. Baudin, C. Lombard-Bohas, 2011, The International journal of biological markers.

Docetaxel-estramustine in localized high-risk prostate cancer: Results of the French Genitourinary Tumor Group GETUG 12 phase III trial.

S. Culine, G. Gravis, Anne-Laure Martin, 2014 .

High Levels of Circulating VEGFR2+ Bone Marrow–Derived Progenitor Cells Correlate with Metastatic Disease in Patients with Pediatric Solid Malignancies

B. Geoerger, G. Vassal, A. Laplanche, 2009, Clinical Cancer Research.

A Meta-Analysis of the Relationship between FGFR3 and TP53 Mutations in Bladder Cancer

Y. Allory, F. Radvanyi, X. Paoletti, 2012, PloS one.

5-Fluorouracil (5-FU) continuous intravenous infusion compared with bolus administration. Final results of a randomised trial in metastatic colorectal cancer.

M. Ducreux, P. Rougier, A. Laplanche, 1997, European journal of cancer.

Cost of prostate image-guided radiation therapy: results of a randomized trial.

J. Bachaud, M. Morelle, R. de Crevoisier, 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

An R function to non-parametric and piecewise analysis of competing risks survival data

Jean-Marie Boher, Thomas Filleron, Andrew Kramar, 2010, Comput. Methods Programs Biomed..

A randomized phase III, factorial design, of cabazitaxel and pelvic radiotherapy in patients with localized prostate cancer and high-risk features of relapse.

J. Carles, A. Laplanche, K. Fizazi, 2014 .

A phase II trial of docetaxel and samarium in patients with bone metastases from castration-refractory prostate cancer (CRPC) and a response or stabilization after induction docetaxel-estramustine.

C. Théodore, V. Haddad, B. Escudier, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prevention of second primary tumors with etretinate in squamous cell carcinoma of oral cavity and oropharynx. Results of a double-blind randomized study

M. Bolla, A. Laplanche, Christian Domenge, 1993 .

Daily versus weekly prostate cancer image-guided radiotherapy: A phase 3, multicenter, randomized trial.

R. Crevoisier, J. Bachaud, M. Bayar, 2018 .

Expression of EPHRIN-A1, SCINDERIN and MHC class I molecules in head and neck cancers and relationship with the prognostic value of intratumoral CD8+ T cells

E. Tartour, S. Chouaib, S. Oudard, 2013, BMC Cancer.

Expression of EPHRIN-A 1 , SCINDERIN and MHC class I molecules in head and neck cancers and relationship with the prognostic value of intratumoral CD 8 + T cells

S. Oudard, P. Vielh, C. Badoual, 2013 .

Polyadenylic-polyuridylic acid plus locoregional and pelvic radiotherapyversus chemotherapy with CMF as adjuvants in operable breast cancer

T. Delozier, J. Petit, M. Namer, 1991, Breast Cancer Research and Treatment.

Quantification of circulating mature endothelial cells using a whole blood four-color flow cytometric assay.

P. Vielh, A. Laplanche, F. Griscelli, 2008, Journal of immunological methods.

Phase II trial of thalidomide in renal-cell carcinoma.

B. Escudier, N. Lassau, A. Laplanche, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.